Ratio Therapeutics Partners with Novartis on SSTR2 Radiotherapeutic for Cancer
US-based Ratio Therapeutics Inc. has entered into a global exclusive licensing and cooperation agreement with...
US-based Ratio Therapeutics Inc. has entered into a global exclusive licensing and cooperation agreement with...